Search results
Jim Huntington, Professor of Molecular Haemostasis at the University of Cambridge, is internationally recognised for elucidating the basic structural mechanisms of proteins that control blood coagulation and for applying this knowledge to develop potential therapeutics.
May 4, 2017 · A University of Cambridge spin-out company has raised £7 million in new funding, which will help in the development of treatments for liver and lung disease. The company, Z Factor Limited, was founded by Professor Jim Huntington of the Cambridge Institute for Medical Research.
Professor Jim Huntington, FMedSci. Public Engagement. Intranet (CIMR only) Basic and translational research into thrombosis, haemophilia and antitrypsin deficiency. General audience summary: Blood must be able to flow to deliver nutrients and signals to cells throughout the body.
View Jim Huntington’s profile on LinkedIn, a professional community of 1 billion members. Professor University of Cambridge · Experience: SDS Therapeutics · Education: Vanderbilt University ·...
- 385
- SDS Therapeutics
- 419
- Greater Cambridge Area
Professor Jim Huntington. The shapes of Z-α1-antitrypsin polymers in solution support the C-terminal domain-swap mechanism of polymerization. Behrens MA, Sendall TJ, Pedersen JS, Kjeldgaard M, , Jensen JK. Biophys J. 2014 Oct 21;107 (8):1905-12. Structure and mechanism of cysteine peptidase gingipain K (Kgp), a major virulence factor of ...
View the profiles of people named Jim Benedetto. Join Facebook to connect with Jim Benedetto and others you may know. Facebook gives people the power to...
Our dedicated specialists fight cancer alongside you every step of the way. Their expert, patient-centered cancer care is delivered with the compassionate, whole-person support that Huntington is known for. These experienced physicians are based in Pasadena, making world-class cancer care available to everyone throughout the San Gabriel Valley.
